Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer Animal Health sees sales growth in first quarter

Pfizer Animal Health sees sales growth in first quarter

6th May 2011

Pfizer Animal Health has experienced a year-on-year rise in sales during the first quarter of 2011.

The Pfizer business unit, which creates vaccines, paraciticides, anti-infectives and other treatments for livestock and companion animals, reported first-quarter revenue of $982 million (598.59 million pounds).

It represented a year-on-year increase of 16 percent, with the final total elevated by $50 million as a result of the recent acquisition of King Pharmaceuticals.

This merger deal, which was completed in March 2011, saw Pfizer Animal Health add a number of new products from King's veterinary medicines unit Alpharma to its portfolio.

According to Jose Francisco Ortiz, vice-president for Pfizer Poultry Health, this has particularly benefited its offerings for poultry producers, allowing it to introduce new feed additives, water-soluble therapeutics and probiotics to its range.

The animal health business's performance contributed to a $16.5 billion first quarter revenue total for the Pfizer group, which was roughly level with last year.ADNFCR-8000103-ID-800522625-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.